These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Blink reflex in Parkinson's disease with levodopa-induced dyskinesia. Iriarte LM; Chacon J; Madrazo J; Chaparro P Funct Neurol; 1989; 4(3):257-61. PubMed ID: 2792861 [TBL] [Abstract][Full Text] [Related]
3. [Effects and side effects of levodopa in parkinsonism - results of a collaborative study. (4) Dyskinesia caused by levodopa]. Mano T Rinsho Shinkeigaku; 1976 Dec; 16(12):877-8. PubMed ID: 1035530 [No Abstract] [Full Text] [Related]
4. Clinical physiology of dopa dyskinesia. Hallett M Ann Neurol; 2000 Apr; 47(4 Suppl 1):S147-50; discussion S150-3. PubMed ID: 10762142 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesia. Lyons KE; Pahwa R Clin Neuropharmacol; 2006; 29(3):148-53. PubMed ID: 16772814 [TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease: progression and mortality in the L-DOPA era. Di Rocco A; Molinari SP; Kollmeier B; Yahr MD Adv Neurol; 1996; 69():3-11. PubMed ID: 8615142 [No Abstract] [Full Text] [Related]
7. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Bezard E; Brotchie JM; Gross CE Nat Rev Neurosci; 2001 Aug; 2(8):577-88. PubMed ID: 11484001 [TBL] [Abstract][Full Text] [Related]
8. New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable. Hadj Tahar A; Grondin R; Grégoire L; Calon F; Di Paolo T; Bédard PJ Adv Neurol; 2003; 91():51-64. PubMed ID: 12442663 [No Abstract] [Full Text] [Related]